We are on a mission to transform the diagnostics of infectious diseases by detecting pathogens involved, through their gas biomarkers.

Chosen as one of the Top 10 diagnostic innovations
at ESCMID Global 2026

Discover our solution BactifyTM

  1. Technology

    Enhancing Gold Standard pathogen cultures, AI and gas biomarkers detection

  2. Value

    Simplifying the process of pathogen detection and identification

    Lowering the cost of care

    Reduction of antibiotic consumption addressing the challenge of Antimicrobial Resistance (AMR)

  3. Team

    2nd venture after successful exit

    Interdisciplinary team comprising scientists, engineers, and clinicians

About Zynnon

We serve the Clinical Diagnostics Microbiology market

Enhancing Gold Standard pathogen cultures through gas biomarkers

Discover Zynnon

We innovate for smarter health.

News

07. 04. 26

Zynnon sponsor at ESCMID – European Society of Clinical Microbiology and Infectious Diseases 2026
06. 11. 25

Zynnon Launches Groundbreaking Diagnostic Platform for Rapid Detection of Bloodstream Infections
20. 10. 24

Zynnon welcomes Dr. Philippe Gadal as an Advisor
26. 09. 24

BIOASTER collaborates with ZYNNON to advance VOC-based detection and identification
12. 09. 24

Zynnon welcomes Dr. Mark Miller as an Advisor

Partners